NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,182 | +179.6% | 123 | +179.5% | 0.00% | +300.0% |
| Q1 2022 | $4,000 | 0.0% | 44 | -10.2% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 49 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $4,000 | -20.0% | 49 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | -99.1% | 49 | -99.2% | 0.00% | -99.2% |
| Q3 2020 | $527,000 | +8.2% | 6,059 | +8.7% | 0.25% | -5.7% |
| Q2 2020 | $487,000 | +9.9% | 5,574 | +3.6% | 0.26% | -14.9% |
| Q1 2020 | $443,000 | -8.5% | 5,380 | +5.3% | 0.31% | +6.2% |
| Q4 2019 | $484,000 | +8.0% | 5,108 | -1.0% | 0.29% | +5.5% |
| Q3 2019 | $448,000 | +2700.0% | 5,160 | +2848.6% | 0.28% | +2650.0% |
| Q2 2019 | $16,000 | -5.9% | 175 | 0.0% | 0.01% | -9.1% |
| Q1 2019 | $17,000 | +13.3% | 175 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $15,000 | 0.0% | 175 | 0.0% | 0.01% | +22.2% |
| Q3 2018 | $15,000 | +15.4% | 175 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $13,000 | -7.1% | 175 | 0.0% | 0.01% | -10.0% |
| Q1 2018 | $14,000 | -6.7% | 175 | 0.0% | 0.01% | -9.1% |
| Q4 2017 | $15,000 | – | 175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |